Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in persistent elevated albuminuria
NCT05268926Phase 2Terminated
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapagliflozin in albuminuria, sponsored by University Medical Center Groningen. Started Feb 2022; status: terminated.
02
Drugs
dapagliflozin
03
Conditions
albuminuria
Beyond the preview
Go deeper on NCT05268926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05268926.